Matches in SemOpenAlex for { <https://semopenalex.org/work/W2553084149> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- W2553084149 endingPage "3177" @default.
- W2553084149 startingPage "3170" @default.
- W2553084149 abstract "Objective: To systematically review the efficacy, side effects and case-fatality rate of levetiracetam (LEV) versus phenytoin (PHT) for seizure prophylaxis of brain injured patients. Methods: Randomized controlled trials of high quality about LEV versus PHT in seizure prophylaxis of brain injured patients from 2000 to 2016 were collected according to the key word PHT, LEV, brain injury in PubMed, Medline, Ovid, Springer, CNKI, Wanfang data and so on. Valid data were extracted to conduct meta-analysis by RevMan 5.3 software according to inclusion and exclusion criteria. Results: A total of 13 English articles were finally included with 2 529 patients in total.Meta-analysis showed that no significant differences were observed in LEV versus PHT at preventing the occurrence of seizures (RR=0.88, 95%CI: 0.61-1.27). No superiority of either drug at preventing early seizures (RR=0.74, 95%CI: 0.42-1.27). As to the occurrence of late seizures, the differences of the two drugs were not statistically significant (RR=0.71, 95%CI: 0.43-1.20). Number of patients with side effect was not statistically significantly different between the two groups (RR=0.73, 95%CI: 0.48-1.11). But significant difference was found between LEV and PHT in discontinuation because of side effect (RR=0.11, 95%CI: 0.06-0.23); no significant differences were noted in the case-fatality rate of patients received pretreatment between the two drugs (RR=1.57, 95%CI: 0.92-2.67). There were no significant differences between the two groups in the length of stay (WMD=-1.03, 95%CI: -4.97-2.91). Conclusions: LEV and PHT demonstrate equal efficacy in seizure prevention after brain injury. The differences are insignificant in the side effect, the case-fatality rate and the length of stay between LEV and PH treatment, but adverse drug reactions requiring change in therapy occur more in PHT. Phenytoin remains the first choice for seizure prevention after brain injury based on the existing evidence, while levetiracetam seems to be a favorable choice where there is risk of drug-drug interactions and drug toxicity. However, very few randomized controlled trials on this topic were found, and larger prospective trials are warranted." @default.
- W2553084149 created "2016-11-30" @default.
- W2553084149 creator A5044892174 @default.
- W2553084149 creator A5079481182 @default.
- W2553084149 date "2016-10-25" @default.
- W2553084149 modified "2023-09-23" @default.
- W2553084149 title "[Comparisons of efficacy and safety of levetiracetam versus phenytoin for seizure prophylaxis in patients with brain injury: a meta analysis]." @default.
- W2553084149 doi "https://doi.org/10.3760/cma.j.issn.0376-2491.2016.39.012" @default.
- W2553084149 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27852418" @default.
- W2553084149 hasPublicationYear "2016" @default.
- W2553084149 type Work @default.
- W2553084149 sameAs 2553084149 @default.
- W2553084149 citedByCount "0" @default.
- W2553084149 crossrefType "journal-article" @default.
- W2553084149 hasAuthorship W2553084149A5044892174 @default.
- W2553084149 hasAuthorship W2553084149A5079481182 @default.
- W2553084149 hasConcept C118552586 @default.
- W2553084149 hasConcept C126322002 @default.
- W2553084149 hasConcept C168563851 @default.
- W2553084149 hasConcept C197934379 @default.
- W2553084149 hasConcept C2777332695 @default.
- W2553084149 hasConcept C2778186239 @default.
- W2553084149 hasConcept C2778337148 @default.
- W2553084149 hasConcept C2778715236 @default.
- W2553084149 hasConcept C42219234 @default.
- W2553084149 hasConcept C44249647 @default.
- W2553084149 hasConcept C71924100 @default.
- W2553084149 hasConcept C82789193 @default.
- W2553084149 hasConcept C95190672 @default.
- W2553084149 hasConceptScore W2553084149C118552586 @default.
- W2553084149 hasConceptScore W2553084149C126322002 @default.
- W2553084149 hasConceptScore W2553084149C168563851 @default.
- W2553084149 hasConceptScore W2553084149C197934379 @default.
- W2553084149 hasConceptScore W2553084149C2777332695 @default.
- W2553084149 hasConceptScore W2553084149C2778186239 @default.
- W2553084149 hasConceptScore W2553084149C2778337148 @default.
- W2553084149 hasConceptScore W2553084149C2778715236 @default.
- W2553084149 hasConceptScore W2553084149C42219234 @default.
- W2553084149 hasConceptScore W2553084149C44249647 @default.
- W2553084149 hasConceptScore W2553084149C71924100 @default.
- W2553084149 hasConceptScore W2553084149C82789193 @default.
- W2553084149 hasConceptScore W2553084149C95190672 @default.
- W2553084149 hasIssue "39" @default.
- W2553084149 hasLocation W25530841491 @default.
- W2553084149 hasOpenAccess W2553084149 @default.
- W2553084149 hasPrimaryLocation W25530841491 @default.
- W2553084149 hasRelatedWork W2022207154 @default.
- W2553084149 hasRelatedWork W2034294964 @default.
- W2553084149 hasRelatedWork W2037442049 @default.
- W2553084149 hasRelatedWork W2058899613 @default.
- W2553084149 hasRelatedWork W2070728679 @default.
- W2553084149 hasRelatedWork W2139520708 @default.
- W2553084149 hasRelatedWork W2347499402 @default.
- W2553084149 hasRelatedWork W2598184698 @default.
- W2553084149 hasRelatedWork W8168635 @default.
- W2553084149 hasRelatedWork W2552754607 @default.
- W2553084149 hasVolume "96" @default.
- W2553084149 isParatext "false" @default.
- W2553084149 isRetracted "false" @default.
- W2553084149 magId "2553084149" @default.
- W2553084149 workType "article" @default.